Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jan 4;21(2):156-162.
doi: 10.1093/ntr/nty033.

Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers

Neal Doran  1   2 , Sarah Dubrava  3 , Robert M Anthenelli  1
Affiliations
Randomized Controlled Trial

Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers

Neal Doran et al. Nicotine Tob Res. .

Abstract

Introduction: Despite effective treatments, relapse to smoking remains a vexing global health problem. One predictor of relapse is depressive symptoms. Medications such as varenicline reduce withdrawal-related symptoms of depression, reducing relapse. This study examined whether varenicline moderated the effect of depressive symptoms on relapse, and whether this varied by region of enrollment.

Methods: Adult smokers (n = 525; 37% male) with past or current, stable major depressive disorder recruited from United States (n = 255), and European (n = 270) sites participated in a randomized, double-blind cessation treatment trial including 12 weeks of varenicline or placebo, with 40-week nontreatment follow-up.

Results: Longitudinal and binary logistic regressions were used to model the probability of sustained abstinence by end of treatment and point-prevalence abstinence in follow-up. The association between depression symptoms and abstinence was moderated by intervention group at end of treatment, and by region during follow-up: more severe symptoms were associated with end-of-treatment relapse for placebo (odds ratio [OR] = 0.91, p = .003), but not varenicline (OR = 0.99, p = .568). During follow-up, increased symptoms of depression predicted greater likelihood of smoking for European (p = .009) but not US participants. Europeans were more likely to be abstinent for both outcomes (p < .01).

Conclusions: These results extend studies demonstrating varenicline is associated with less withdrawal-related depression, and suggest it aids cessation even in smokers with depressive symptoms. Findings also suggest regional differences in the relationship between depressive symptoms and cessation that may be related to differences in prevalence.

Implications: This study indicates varenicline may aid cessation partially by reducing withdrawal-related symptoms of depression. It also suggests that the impact of depressive symptoms on cessation varies regionally, and that this variation may be related to differences in smoking prevalence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Past week (7-day) point prevalence abstinence rate, weeks 13–52, by treatment and region.
See this image and copyright information in PMC

References

    1. CDC. The Health Consequences of Smoking: A Report of the Surgeon General Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2004. www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm. Accessed March 6, 2014.
    1. CDC. Vital signs: current cigarette smoking among adults aged > 18 years with mental illness—United States, 2009–2011. MMWR Morb Mortal Wkly Rep. 2013;62:81–87. - PMC - PubMed
    1. WHO. WHO Report on the Global Tobacco Epidemic. Geneva: World Health Organization; 2011.
    1. Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged > 18 years—United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1227–1232. - PubMed
    1. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29–38. - PubMed

Publication types